Genome editing using the CRISPR/Cas system has revolutionized the field of genetic engineering, offering unprecedented opportunities for therapeutic applications . Despite the numerous ongoing clinical trials focusing on genome editing, recent studies emphasize the therapeutic promise of gene editing using CRISPR/Cas technology. However, it is worth noting that the complete attainment of the inherent capabilities of therapy in humans is yet to be accomplished.
View Article and Find Full Text PDF